Haleon plc (HLN.L)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.
Company Info
Highlights
£35.31B
£0.13
30.03
1.71
£5.69B
£3.63B
£1.20B
£306.54 - £400.65
£399.29
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Haleon plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Haleon plc had a return of 3.47% year-to-date (YTD) and 25.09% in the last 12 months.
HLN.L
3.47%
6.06%
5.03%
25.09%
N/A
N/A
^GSPC (Benchmark)
2.90%
3.70%
10.94%
22.18%
12.41%
11.21%
Monthly Returns
The table below presents the monthly returns of HLN.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.72% | 3.47% | |||||||||||
| 2024 | -0.05% | 3.09% | 1.79% | 1.92% | -4.24% | -0.77% | 8.37% | 9.86% | 2.85% | -5.22% | 0.51% | 0.83% | 19.48% |
| 2023 | -0.95% | -0.71% | 0.77% | 9.01% | -9.34% | 1.27% | 4.36% | -3.57% | 5.69% | -3.33% | 0.17% | -2.55% | -0.45% |
| 2022 | -11.58% | -11.29% | 7.88% | -4.03% | 6.01% | 15.22% | -0.80% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 86, HLN.L is among the top 14% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Haleon plc (HLN.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Haleon plc provided a 1.59% dividend yield over the last twelve months, with an annual payout of £0.06 per share.
| Period | TTM | 2024 | 2023 |
|---|---|---|---|
| Dividend | £0.06 | £0.06 | £0.04 |
Dividend yield | 1.59% | 1.64% | 1.31% |
Monthly Dividends
The table displays the monthly dividend distributions for Haleon plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | £0.00 | £0.00 | £0.00 | ||||||||||
| 2024 | £0.00 | £0.00 | £0.04 | £0.00 | £0.00 | £0.00 | £0.00 | £0.02 | £0.00 | £0.00 | £0.00 | £0.00 | £0.06 |
| 2023 | £0.02 | £0.00 | £0.00 | £0.00 | £0.00 | £0.02 | £0.00 | £0.00 | £0.00 | £0.00 | £0.04 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Haleon plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Haleon plc was 25.41%, occurring on Sep 5, 2022. Recovery took 106 trading sessions.
The current Haleon plc drawdown is 1.64%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -25.41% | Jul 18, 2022 | 35 | Sep 5, 2022 | 106 | Feb 6, 2023 | 141 |
| -12.73% | Apr 21, 2023 | 55 | Jul 11, 2023 | 264 | Jul 25, 2024 | 319 |
| -10.15% | Sep 18, 2024 | 41 | Nov 13, 2024 | — | — | — |
| -7.76% | Feb 22, 2023 | 14 | Mar 13, 2023 | 17 | Apr 5, 2023 | 31 |
| -2.27% | Apr 11, 2023 | 6 | Apr 18, 2023 | 2 | Apr 20, 2023 | 8 |
Volatility
Volatility Chart
The current Haleon plc volatility is 3.98%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Haleon plc compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for HLN.L in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, HLN.L has a PE value of 30.0. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for HLN.L in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, HLN.L has a PEG value of 1.7. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Haleon plc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |